Membrane Type 1 Matrix Metalloproteinase Expression in Human Atherosclerotic Plaques
- 22 June 1999
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (24) , 3103-3109
- https://doi.org/10.1161/01.cir.99.24.3103
Abstract
Background—Matrix metalloproteinases (MMPs) are expressed in atherosclerotic plaques, where in their active form, they may contribute to vascular remodeling and plaque disruption. In this study, we tested the hypothesis that membrane type 1 MMP (MT1-MMP), a novel transmembrane MMP that activates pro-MMP-2 (gelatinase A), is expressed in human atherosclerotic plaques and that its expression is regulated by proinflammatory molecules. Methods and Results—MT1-MMP expression was examined in normal and atherosclerotic human arteries by immunocytochemistry with specific antibodies. MT1-MMP expression in human saphenous vein–derived smooth muscle cells (SMCs) maintained in tissue culture was determined under basal conditions and in response to proinflammatory molecules (interleukin [IL]-1α, tumor necrosis factor [TNF]-α, and oxidized LDL [ox-LDL]) by use of Northern blot and ribonuclease protection assays for mRNA, Western blot and immunoprecipitation for protein, and gelatin zymography for catalytic activity. Medial SMCs of normal vessel wall expressed MT1-MMP. In atherosclerotic arteries, MT1-MMP expression was noted within the complex atheroma colocalizing with SMCs and macrophages (Mφ). Cultured SMCs constitutively expressed MT1-MMP mRNA and protein, which increased 2- to 4-fold over control in a time-dependent manner within 4 to 8 hours of exposure to IL-1α, TNF-α, and ox-LDL (thiobarbituric acid–reactive substances, 13.4 nmol/mg LDL protein), whereas native LDL had no effect. Flow cytometry revealed MT1-MMP expression by human monocyte-derived Mφ, which increased 3.8-fold over baseline within 6 hours after exposure to 10 ng/mL TNF-α. Conclusions—This study demonstrates that MT1-MMP, an activator of pro-MMP-2, is expressed by SMCs and Mφ in human atherosclerotic plaques. Furthermore, proinflammatory molecules upregulate MT1-MMP expression in vascular SMCs and Mφ. Thus, activation of SMCs and Mφ by proinflammatory molecules may influence extracellular matrix remodeling in atherosclerosis by regulating MT1-MMP expression.Keywords
This publication has 19 references indexed in Scilit:
- Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.Journal of Clinical Investigation, 1996
- Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3Cell, 1996
- Nitric Oxide Inhibits Macrophage-Colony Stimulating Factor Gene Transcription in Vascular Endothelial CellsJournal of Biological Chemistry, 1995
- Proteolytic remodeling of extracellular matrixCurrent Opinion in Cell Biology, 1995
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- A matrix metalloproteinase expressed on the surface of invasive tumour cellsNature, 1994
- Induction of collagenase and stromelysin gene expression by mechanical injury in a vascular smooth muscle‐derived cell lineJournal of Cellular Physiology, 1993
- Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathwaysExperimental Cell Research, 1992
- Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.Journal of Clinical Investigation, 1990
- Oxidative Autoactivation of Latent Collagenase by Human NeutrophilsScience, 1985